SCHEMBL24835534

SCHEMBL24835534

CSc1cc2cn[nH]c(=O)c2cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
HSD17B10 Q99714 2/20 0.43
PARP1 P09874 1/20 0.43
PRKCI P41743 1/20 0.43
PDE4B Q07343 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MKNK1 Q9BUB5 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
ADORA2A P29274 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
XDH P47989 1/20 0.35
RAB9A P51151 1/20 0.35
BLM P54132 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE9A O76083 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19153192 0.77 ALDH1A1 (0.47) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL25198709 0.77 HSD17B10 (0.49) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL26846259 0.75 CHEK1 (0.42) ALDH1A1TDP1MKNK1MAPTRAB9A
SCHEMBL4676008 0.74 ALDH1A1 (0.47) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL18238681 0.73 ALDH1A1 (0.43) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL23579452 0.71 ALDH1A1 (0.41) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL25310111 0.70 ALDH1A1 (0.43) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL31427015 0.70 ALDH1A1 (0.43) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL25308701 0.70 ALDH1A1 (0.40) ALDH1A1HSD17B10PARP1PRKCIPDE4B
SCHEMBL23578929 0.68 ALDH1A1 (0.38) ALDH1A1HSD17B10PARP1PRKCIPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000993-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO INC (US) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230000993-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT ALDH1A1 2151/4885HSD17B10 3435/4885PARP1 2195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.